EIM
CSTL icon

Essex Investment Management’s Castle Biosciences CSTL Stock Holding History

Essex Investment Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-480,918
Closed -$10.9M – 381
2023
Q1 		$10.9M Buy
480,918
+27,601
+6% +$674K 1.59% 5
2022
Q4 		$10.7M Buy
453,317
+16,682
+4% +$387K 1.66% 5
2022
Q3 		$11.4M Buy
436,635
+18,840
+5% +$528K 1.82% 5
2022
Q2 		$9.17M Buy
417,795
+300,550
+256% +$6.98M 1.48% 6
2022
Q1 		$5.26M Buy
117,245
+25,310
+28% +$1.05M 0.66% 44
2021
Q4 		$3.94M Sell
91,935
-3,939
-4% -$206K 0.45% 60
2021
Q3 		$6.38M Sell
95,874
-847
-0.9% -$59.6K 0.78% 28
2021
Q2 		$7.09M Buy
96,721
+49,103
+103% +$3.24M 0.82% 24
2021
Q1 		$3.26M Buy
47,618
+12,576
+36% +$945K 0.4% 75
2020
Q4 		$2.35M Sell
35,042
-5,673
-14% -$308K 0.29% 108
2020
Q3 		$2.1M Buy
40,715
+1,235
+3% +$54.9K 0.3% 111
2020
Q2 		$1.49M Buy
+39,480
New +$1.35M 0.24% 134
2020
Q1 		– Sell
-54,183
Closed -$1.86M – 405
2019
Q4 		$1.86M Buy
54,183
+945
+2% +$23.1K 0.23% 146
2019
Q3 		$963K Buy
+53,238
New +$1.18M 0.14% 213

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Investment Management's CSTL Position: Q2 2023 in Review

Essex Investment Management sold out of Castle Biosciences (CSTL) in Q2 2023, closing a stake of 480,918 shares — an estimated $10.9M sold.

Essex Investment Management first reported a position in CSTL in Q3 2019 and held it in 14 quarters. The position peaked at $11.4M in Q3 2022. 130 funds tracked by Wall St. Rank hold CSTL as of Q2 2023.

  • Essex Investment Management reported no remaining Castle Biosciences position as of Q2 2023 after selling out during the quarter.
  • Essex Investment Management sold 480,918 Castle Biosciences shares in Q2 2023, an estimated $10.9M.
  • Essex Investment Management first reported a position in Castle Biosciences in Q3 2019 and held it in 14 quarters.
  • Essex Investment Management's Castle Biosciences position peaked at $11.4M in Q3 2022.
  • 130 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2023.

Based on Essex Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.